{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:20:04Z","timestamp":1773660004304,"version":"3.50.1"},"publisher-location":"Boston, MA","reference-count":79,"publisher":"Springer US","isbn-type":[{"value":"9781489918154","type":"print"},{"value":"9781489918130","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997]]},"DOI":"10.1007\/978-1-4899-1813-0_7","type":"book-chapter","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T15:37:21Z","timestamp":1373384241000},"page":"41-53","source":"Crossref","is-referenced-by-count":47,"title":["Involvement of the Multiple Tumor Suppressor Genes and 12-Lipoxygenase in Human Prostate Cancer"],"prefix":"10.1007","author":[{"given":"Xiang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur T.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth V.","family":"Honn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF02893578","volume":"1","author":"X Gao","year":"1995","unstructured":"X. Gao, and K.V. Honn. Recessive oncogenes: Current status. Pathol. Oncol. Res. 1:7\u201322 (1995).","journal-title":"Pathol. Oncol. Res."},{"key":"7_CR2","first-page":"475","volume":"2","author":"X Gao","year":"1995","unstructured":"X. Gao, A.T. Porter, and K.V. Honn. Tumor suppressor genes and their involvement in human prostate cancer. Cancer Mol. Biol. 2:475\u2013498 (1995).","journal-title":"Cancer Mol. Biol."},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.2565047","volume":"244","author":"B Vogelstein","year":"1989","unstructured":"B. Vogelstein, E.R. Fearon, S.E. Kern, S.R. Hamilton, C. Preisinger, Y. Nakamura, and R. White. Allelotype of colorectal carcinomas. Science (Washington DC) 244:207\u2013211 (1989).","journal-title":"Science (Washington DC)"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.2300823","volume":"247","author":"R Bookstein","year":"1990","unstructured":"R. Bookstein, J-Y. Shew, P.-L. Chen, P. Scully, and W.H. Lee. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC) 247:712\u2013715 (1990).","journal-title":"Science (Washington DC)"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1073\/pnas.87.19.7762","volume":"87","author":"R Bookstein","year":"1990","unstructured":"R. Bookstein, P. Rio, and S. Madreperla. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA. 87:7762\u20137766 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/pros.2990210207","volume":"21","author":"FH Sarkar","year":"1992","unstructured":"F.H. Sarkar, W. Sakr, and Y.-W. Li. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate 21:145\u2013152 (1992).","journal-title":"Prostate"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1464-410X.1994.tb07602.x","volume":"73","author":"SMA Phillips","year":"1994","unstructured":"S.M.A. Phillips, D.G. Morton, S.J. Lee, D.M.A. Wallace, and J.P. Neoptolemos, Loss of heterozygosity of the retinoblastoma and adenomatous polyposis succeptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Brit. J. Urol. 73:390\u2013395 (1994).","journal-title":"Brit. J. Urol."},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"8751","DOI":"10.1073\/pnas.87.22.8751","volume":"87","author":"BS Carter","year":"1990","unstructured":"B.S. Carter, C.M. Ewing, W.S. Ward, B.F. Treiger, T.W. Aalders, J.A. Schalken, J.I. Epstein, and W.B. Isaacs. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA. 87:8751\u20138755 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"7_CR9","first-page":"4716","volume":"51","author":"WB Isaacs","year":"1991","unstructured":"W.B. Isaacs, B.S. Carter, and C.M. Ewing. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51:4716\u20134720 (1991).","journal-title":"Cancer Res"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/370174a0","volume":"370","author":"B Vogelstein","year":"1994","unstructured":"B. Vogelstein, and K.W Kinzler. X-rays strike p53 again. Nature 370:174\u2013175 (1994).","journal-title":"Nature"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/371021a0","volume":"371","author":"E White","year":"1994","unstructured":"E. White. p53, guardian of Rb. Nature 371:21\u201322 (1994).","journal-title":"Nature"},{"key":"7_CR12","first-page":"4855","volume":"54","author":"MS Greenblatt","year":"1994","unstructured":"M.S. Greenblatt, W.P. Bennett, M. Hollstein, and C.C. Harris. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855\u20134878 (1994).","journal-title":"Cancer Res."},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pros.2990220104","volume":"22","author":"PJ Veldhuizen Van","year":"1993","unstructured":"P. J. Van Veldhuizen, R. Sadasivan, F. Garcia, M. S. Austenfeld, and R.L. Stephens. Muatnt p53 expression in prostate carcinoma. Prostate 22:23\u201330 (1993).","journal-title":"Prostate"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00000441-199305000-00001","volume":"305","author":"PJ Veldhuizen Van","year":"1993","unstructured":"P.J. Van Veldhuizen, R. Sadasivan, R. Cherian, T. Dwyer, and R.L. Stephens. p53 expression in incidental prostatic cancer. Am. J. Med. Sci. 305:275\u2013279 (1993).","journal-title":"Am. J. Med. Sci."},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF01611179","volume":"421","author":"Y Soini","year":"1992","unstructured":"Y. Soini, P. P\u00e4akk\u00f6, K. Nuorva, D. Kamel, D.R Lane, and K. Vahakangas. Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Arch. A. Pathol. Anat. Histopathol. 421:223\u2013228 (1992).","journal-title":"Arch. A. Pathol. Anat. Histopathol."},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-5347(17)35458-7","volume":"150","author":"PJ Effert","year":"1993","unstructured":"P.J. Effert, R.H. McCoy, P.J. Walther, E.T. Lui. p53 gene alterations in human prostate carcinoma. J. Urol. 150:257\u2013261 (1993).","journal-title":"J. Urol."},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1464-410X.1992.tb15632.x","volume":"69","author":"SJ Thompson","year":"1992","unstructured":"S.J. Thompson, K. Mellon, R.G. Charlton, C Marsh, M. Robinson and D.E. Neal. P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyper-plasia. Br. J. Urol. 69:609\u2013613 (1992).","journal-title":"Br. J. Urol."},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1349-7006.1994.tb02967.x","volume":"85","author":"M Watanabe","year":"1994","unstructured":"M. Watanabe, T. Ushijima, H. Kakiuchin T. Shiraishi, R. Yatani, J. Shimazaki, T. Dotake, T. Sugimrua, and M. Nagao. p53 gene mutations in human prostate cancers in Japan: Different mutation spectra between Japan and Western countries. Jap. J. Cancer Res. 85:904\u2013910 (1994).","journal-title":"Jap. J. Cancer Res."},{"key":"7_CR19","first-page":"287","volume":"145","author":"M Ittmann","year":"1994","unstructured":"M. Ittmann, R. Wieczorek, P. Heller, A. Dave, J. Provet, and J. Krolewski. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas. Am. J. Pathol. 145:287\u2013293 (1994).","journal-title":"Am. J. Pathol."},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/bjc.1993.423","volume":"68","author":"T Uchida","year":"1993","unstructured":"T. Uchida, C Wada, T. Shitara, S. Egawa, and D. Koshiba. Infrequent involvement of p53 gene-mutations in the tumorigenesis of Japanese prostate-cancer. Brit. J. Cancer 68:751\u2013755 (1993).","journal-title":"Brit. J. Cancer"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1093\/jnci\/85.20.1657","volume":"85","author":"NM Navone","year":"1993","unstructured":"N.M. Navone, P. Troncoso, L.L. Pisters, T.L. Goodrow, J.L. Palmer, W.W. Nichols, A. von Eschenbach, and CJ. Conti. p53 protein accumulation an gene mutation in the progression of human prostate carcinoma. J. Natl. Cancer Inst. 85:1657\u20131669 (1993).","journal-title":"J. Natl. Cancer Inst."},{"key":"7_CR22","first-page":"3369","volume":"53","author":"R Bookstein","year":"1993","unstructured":"R. Bookstein, D. MacGrogan, S.G. Hilsenbeck, F. Sharkey, and D.C Allred. p53 is mutated in a subset of advanced stage prostate cancers. Cancer Res. 53:3369\u201373 (1993).","journal-title":"Cancer Res."},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0046-8177(94)90177-5","volume":"25","author":"BVS Kallakury","year":"1994","unstructured":"B.V.S. Kallakury, J. Figge, J.S. Ross, H.A.G. Fisher, H.L. Figge, and T.A. Jennings. Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma. Hum. Pathol. 25:92\u201397 (1994).","journal-title":"Hum. Pathol."},{"key":"7_CR24","doi-asserted-by":"crossref","unstructured":"X. Gao, A.T. Porter, J.E. Pontes, and K.V. Honn. Diagnostic and prognostic markers for human prostate cancer. Prostate In press (1996).","DOI":"10.1002\/(SICI)1097-0045(19970601)31:4<264::AID-PROS8>3.0.CO;2-K"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/jnci\/85.22.1856","volume":"85","author":"FJ Meyers","year":"1993","unstructured":"F.J. Meyers, S.-G. Chi, J.R. Fishman, R.W. deVere White, and P.H. Gumerlock. p53 mutations in benign prosatic hyperplasia. J. Natl. Cancer Inst. 85:1856\u20131858 (1993).","journal-title":"J. Natl. Cancer Inst."},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/jnci\/86.12.926","volume":"86","author":"S-G Chi","year":"1994","unstructured":"S.-G. Chi, R.W. deVere White, F.J. Meyers, D.B. Siders, F. Lee, P.H. Gumerlock. p53 in prostate cancer: frequent expressed transition mutations. J. Natl. Cancer Inst. 86:926\u2013933 (1994).","journal-title":"J. Natl. Cancer Inst."},{"key":"7_CR27","first-page":"357","volume":"1","author":"YQ Chen","year":"1994","unstructured":"Y.Q. Chen, X. Gao, D. Grignon, F.H. Sarkr, W. Sakr, K.V. Honn, J.S. Borders, and J.D. Crissman. Multiple mechanisms of p53 inactivation in human prostate cancer. Cancer Mol. Biol. 1:357\u2013367 (1994).","journal-title":"Cancer Mol. Biol."},{"key":"7_CR28","first-page":"2723","volume":"53","author":"X Gao","year":"1993","unstructured":"X. Gao, K.V. Honn, D. Grignon, W. Sakr, Y.Q. Chen. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 53:2723\u20132727 (1993).","journal-title":"Cancer Res."},{"key":"7_CR29","first-page":"111","volume":"6","author":"X Gao","year":"1995","unstructured":"X. Gao, A. Zacharek, D. Grignon, H. Liu, W. Sakr, A.T. Porter, Y.Q. Chen, and K.V. Honn. High frequency of loss of expression and allelic deletion of the APC and MCC genes in human prostatic carcinomas. Int. J. Oncol. 6:111\u2013117 (1995).","journal-title":"Int. J. Oncol."},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.2294591","volume":"247","author":"ER Fearon","year":"1990","unstructured":"E.R. Fearon, K.R. Cho, J.M. Nigro, S.E. Kern, J.W. Simons, J. M. Ruppert, S.R. Hamilton, A.C. Preisinger, G. Thomas, K.W. Kinzler, and B. Vogelstein. Identifi-cation of a chromosome 18q gene that is altered in colorectal carcinoma. Science (Washington DC), 247:49\u201356 (1990).","journal-title":"Science (Washington DC)"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1006\/geno.1994.1102","volume":"19","author":"KR Cho","year":"1994","unstructured":"K.R. Cho, J.D. Oliner, J.W. Simons, L. Hedrick, E.R. Fearon, A.C. Preisinger P. Hedge, G.A. Silverman, and B. Vogelstein. The DCC gene-structural-analysis and mutations in colorectal carcinomas. Genomics, 19:525\u2013531 (1994).","journal-title":"Genomics"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1101\/gad.8.10.1174","volume":"8","author":"L Hedrick","year":"1994","unstructured":"L. Hedrick, K.R. Cho, and E.R. Fearon. The DCC gene product in cellular differentiation and colorectal tumorgenesis. Genes Dev. 8:1174\u20131183 (1994).","journal-title":"Genes Dev."},{"key":"7_CR33","first-page":"4493","volume":"54","author":"MA Reale","year":"1994","unstructured":"M.A. Reale, G. Hu, A.I. Zafar, R.H. Getzenberg, S.M. Levine, and E.R. Fearon. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res. 54:4493\u20134501 (1994).","journal-title":"Cancer Res."},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1083\/jcb.124.6.1017","volume":"124","author":"WE Pierceall","year":"1994","unstructured":"WE. Pierceall, K.R. Cho, R. H. Getzenberg, M.A. Reale, L. Hedrick, B. Vogelstein, and E.R. Fearon, NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC 12 pheochromo-cytoma cells. J Cell Biol. 124:1017\u20131027. (1994).","journal-title":"J Cell Biol."},{"key":"7_CR35","first-page":"533","volume":"7","author":"R Narayanan","year":"1992","unstructured":"R. Narayanan, K.G. Lawlor, R.Q. Schaapvel, K.R. Cho, B. Vogelstein, P.B.V. Tran, M.P. Osborne, and N.T. Telang. Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-I fibroblasts. Oncogene 7:533\u2013561 (1992).","journal-title":"Oncogene"},{"key":"7_CR36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0022-5347(17)35186-8","volume":"151","author":"SF Brewster","year":"1994","unstructured":"S.F. Brewster S. Browne, and K.W. Brown, Somatic allelic loss at the DCC, APC, NM23-H1 and P53 tumorsuppressor gene loci in human prostatic-carcinoma. J. Urol. 151:1073\u20131077 (1994).","journal-title":"J. Urol."},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1349-7006.1994.tb02957.x","volume":"85","author":"H Suzuki","year":"1994","unstructured":"H. Suzuki, S. Aida, S. Akimoto, T. Igarashi, R. Tatani, and J. Shimazaki. State of adenomatous polyposis coli gene and RAS oncogenes in Japanese prostate cancer. Jap. J. Cancer Res. 85:847\u2013852 (1994).","journal-title":"Jap. J. Cancer Res."},{"key":"7_CR38","first-page":"2999","volume":"9","author":"X Gao","year":"1994","unstructured":"X. Gao, N. Wu, D. Grignon, A. Zacharek, H. Liu, A. Salkowski, G. Li, W. Sakr, F. Sarkar, A.T. Porter, Y.Q. Chen, and K.V. Honn. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 9:2999\u20133003 (1994).","journal-title":"Oncogene"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","volume":"75","author":"R Fishel","year":"1993","unstructured":"R. Fishel, M. Kay-Lescoe, M.R.S. Rao, N.G. Copeland, N.A. Jenkins, J. Garber, M. Kane, and R. Kolodner. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027\u20131038 (1993).","journal-title":"Cell"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/0092-8674(93)90330-S","volume":"75","author":"FS Leach","year":"1993","unstructured":"F.S. Leach, N.C. Nicolaides, N. Paradopoulos, B. Liu, J. Jen, R. Parsons, P. Peltomaki, P. Sistonen, L.A. Alionen, M. Nystrom-Lahti, X Y. Guan, J. Zhang, P.S. Meltzer, W. Yu, F.T. Kao, D.J. Chen, K.M. Cerosaletti, R.E.K. Fournier, S. Todd, T. Lewis, R.J. Leach, S.L. Naylor, J. Weissenbach, J.P. Mecklin, H. Jarvinen, G.M. Petersen, S.R. Hamilton, J. Green, J. Jass, P. Watson, H.T. Lynch, J.M. Trent A. de la Chapelle, K.W. Kinzler, and B. Vogelstein. Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215\u20131225 (1993).","journal-title":"Cell"},{"key":"7_CR41","first-page":"242","volume":"55","author":"RD Kolodner","year":"1995","unstructured":"R.D. Kolodner, N.R. Hall, J. Lipford, M.F. Kane, P.T. Morrison, P.J. Finan, J. Burn, P. Chapman, C. Earabino, E. Merchant, and D.T. Bishop. Structure of teh human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlhl mutations. Cancer Res. 55:242\u2013248 (1995).","journal-title":"Cancer Res."},{"key":"7_CR42","first-page":"4308","volume":"54","author":"M Koi","year":"1994","unstructured":"M. Koi, A. Umar, D.P. Chauhan, S.P. Cherian, J.M. Carethers, T.A. Kunkel, and C.R. Bolard. Human chromosome 3 corrects micmatch repair deficiency and microsatellite instability and reduces N-Methyl-N\u2019-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 54:4308\u20134312 (1994).","journal-title":"Cancer Res."},{"key":"7_CR43","first-page":"1019","volume":"10","author":"T ychida","year":"1995","unstructured":"T. ychida, C. Wada, C. Wang, H. Ishida, S. Egawa, E. Yokiyama, H. Ohtani, and E. Koshiba. Microsatellite instability in prostate cancer. Oncogene, 10:1019\u20131022 (1995).","journal-title":"Oncogene"},{"key":"7_CR44","first-page":"75A","volume":"72","author":"MR Emmert-Buck","year":"1995","unstructured":"M.R. Emmert-Buck, M.J. Roth, J. Teruya-Feldstein, LJ. Medeiros, W.G. Stetler-Stevenson, L.A. Liotta, and Z. Zhuang. Detection of nm23 microsatellite instability in microdissected human prostate cancer specimens. Lab. Invest. Abst. No. 427, 72:75A (1995).","journal-title":"Lab. Invest. Abst. No. 427"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/0888-7543(91)90059-N","volume":"11","author":"K Kunimi","year":"1991","unstructured":"K. Kunimi, U.S.R. Bergerheim, I-L. Larsson, P. Ekman, and V.P. Collins. Alllotyping of human prostatic adenocarcinoma. Genomics 11:530\u2013536 (1991).","journal-title":"Genomics"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/gcc.2870030308","volume":"3","author":"USR Bergerheim","year":"1993","unstructured":"U.S.R. Bergerheim, K. Kumimi, V.P. Collins, and P. Ekman. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Gene Chromosom. Cancer 3:215\u2013220 (1993).","journal-title":"Gene Chromosom. Cancer"},{"key":"7_CR47","first-page":"297","volume":"1","author":"X Gao","year":"1994","unstructured":"X. Gao, N. Wu, D. Grignon, W. Sakr, A.T. Porter, K.V. Honn. Allelic deletion of microsatellite loci on chromosome 6p in a subset of human prostate cancer. Cancer Mol. Biol. 1:297\u2013304 (1994).","journal-title":"Cancer Mol. Biol."},{"key":"7_CR48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/j.1460-2075.1995.tb07031.x","volume":"14","author":"M Nakanishi","year":"1995","unstructured":"M. Nakanishi, R.S. Robetorye, G.R. Adami, O.M. Pereira-Smith, and J.R. Smith, Identification of the active region of the DNA synthesis inhibitory gene p21 Sdi1\/CIP1\/WAF1. EMBO J. 14:555\u2013563 (1995).","journal-title":"EMBO J."},{"key":"7_CR49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1091\/mbc.6.4.387","volume":"6","author":"JW Harper","year":"1995","unstructured":"J.W. Harper, S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M.P. Fox, and N. Wei. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:387\u2013400 (1995).","journal-title":"Mol. Biol. Cell."},{"key":"7_CR50","first-page":"1395","volume":"11","author":"X Gao","year":"1995","unstructured":"X. Gao, Y.Q. Chen, N. Wu, D.J. Grignon, W. Sakr, A.T. Porter, K.V. Honn. Somatic mutations of the WAF1\/CIP1 gene in primary prostate cancer. Oncogene 11:1395\u20131398 (1995).","journal-title":"Oncogene"},{"key":"7_CR51","first-page":"1301","volume":"5","author":"A Elbendary","year":"1994","unstructured":"A. Elbendary, A. Berchuck, P. Davis, L. Havrilesky, R.C.Jr. Bast, J.D. Iglehart, and J.R. Marks. Transforming growth factor b1 can induce CIP1\/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Grow. Different. 5:1301\u20131307 (1994).","journal-title":"Cell Grow. Different."},{"key":"7_CR52","first-page":"3407","volume":"9","author":"MS Sheikh","year":"1994","unstructured":"M.S. Sheikh, X.-S. Li, J.-C. Chen, Z.-M. Shao, J.V. Ordonez, and J.A. Fontana, Mechanisms of regulation of Waf1\/CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407\u20133415 (1994).","journal-title":"Oncogene"},{"key":"7_CR53","first-page":"3397","volume":"9","author":"H Jiang","year":"1994","unstructured":"H. Jiang, J. Lin, Z.-Z. Su, R.R. Collari, E. Huberman, and P.B. Fisher. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1\/CIP1, expression in the absence of p53. Oncogene 9:3397\u20133406 (1994).","journal-title":"Oncogene"},{"key":"7_CR54","first-page":"3389","volume":"9","author":"RA Steinman","year":"1994","unstructured":"R.A. Steinman, B. Hoffman, A. Iro, C. Cuilouf, D.A. Liebermann, and M.E. El-Houseini. Induction of p21 (WAF-1\/CIP1) during differentiation. Oncogene 9:3389\u20133396 (1994).","journal-title":"Oncogene"},{"key":"7_CR55","first-page":"668","volume":"55","author":"W Zhang","year":"1995","unstructured":"W. Zhang, L. Graso, C.D. McClain, A.M. Gambel, Y. Cha. S. Travali, A.B. Deisseroth, and W.E. Mercer. p53-independent induction of WAF\/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte\/ macrophage differentiation. Cancer Res. 55:668\u2013674 (1995).","journal-title":"Cancer Res"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1126\/science.7863327","volume":"267","author":"O Halevy","year":"1995","unstructured":"O. Halevy, B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, A.B. and Lassar. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC) 267:1018\u20131021 (1995).","journal-title":"Science (Washington DC)"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.7863329","volume":"267","author":"SB Parker","year":"1995","unstructured":"S.B. Parker, G. Eichele, P. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elldge. p53-independent expression of p21Cip1 in muscle and other terminally differentiation cells. Science (Washington DC) 267:1024\u20131027 (1995).","journal-title":"Science (Washington DC)"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, E. Mercer, K.W. Kinzler, and B. Vogelstein. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817\u2013825 (1993).","journal-title":"Cell"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. The p21 Cdk-interaction protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805\u2013816 (1993).","journal-title":"Cell"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/374386a0","volume":"374","author":"J Chen","year":"1995","unstructured":"J. Chen, P.K. Jackson, M.W. Kirchner, and A. Dutta. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature (Lond). 374:386\u2013388 (1995).","journal-title":"Nature (Lond)."},{"key":"7_CR61","first-page":"6061","volume":"54","author":"J Trapman","year":"1994","unstructured":"J. Trapman, H.F.B.M. Sleddens, M.M. van der Weiden, W.N.M. Dinjens, J.J. Konig, F.H. Schroder, P.W. Faber, and F.T. Bosman, Loss of heterozygosity of chromo-some 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res. 54:6061\u20136064 (1994).","journal-title":"Cancer Res."},{"key":"7_CR62","first-page":"3869","volume":"53","author":"GS Bova","year":"1993","unstructured":"G.S. Bova, B.S. Carter, M.J.G. Bussemakers, M. Emi, Y. Fujiwara, N. Kyprianou, S.C. Jacobs, J.C. Robinson, J.I. Epstein, P.C. Walsh, W.B. Isaacs. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res. 53:3869\u201373 (1993).","journal-title":"Cancer Res."},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/gcc.2870100302","volume":"10","author":"D Macgrogan","year":"1994","unstructured":"D. Macgrogan, A. Levy, D. Bostwick, M. Wagner, D. Wells, and R. Bookstein. Loss of chromosome arm 8p loci in prostate-cancer-mapping by quantitative allelic imbalance. Gene Chrom Cancer 10:151\u2013159 (1994).","journal-title":"Gene Chrom Cancer"},{"key":"7_CR64","first-page":"3071","volume":"9","author":"H Matsuyama","year":"1994","unstructured":"H. Matsuyama, Y. Pan, L. Skoog, B. Tribukait, K. Naito, P. Ekman, P. Lichter, U.S.R. Bergerheim. Deletion mapping of chromosome 8p in prostatecancer by fluorescence in situ hybridization. Oncogene 9:3071\u20133076(1994).","journal-title":"Oncogene"},{"key":"7_CR65","first-page":"2121","volume":"11","author":"J Kagan","year":"1995","unstructured":"J. Kagan, J. Stein, R.J. Babaian, Y.-S. Joe, L.L. Pisters, A.B. Glassman, A.C. von Eschenbach, and P. Troncoso. Homozygous deletion at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene 11:2121\u20132126 (1995).","journal-title":"Oncogene"},{"key":"7_CR66","first-page":"8","volume-title":"Abst. Book, Basic and clinical aspects of prostate cancer","author":"GS Bova","year":"1994","unstructured":"G.S. Bova, M.J.G. Bussmakers, J.C. Robinson, D. MacGrogan, A. Levy, R. Bookstein, and W.B. Isaacs. Homozygous deletion mapping of a one m egabase region of 8p22 in a human prostate cancer. Abst. Book, Basic and clinical aspects of prostate cancer, Palm Springs, CA, USA, Abstract No. A-4, December 8\u201312 (1994)."},{"key":"7_CR67","first-page":"6370","volume":"54","author":"JC Zenklusen","year":"1994","unstructured":"J. C. Zenklusen, C. Thompson, P. Troncoso, J. Kagan, and C.J. Conti, Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppre-ssor gene at 7q31.1. Cancer Res. 54:6370\u20136373 (1994).","journal-title":"Cancer Res."},{"key":"7_CR68","first-page":"6249","volume":"54","author":"CW Rinker-Schaeffer","year":"1994","unstructured":"C.W. Rinker-Schaeffer, A.L. Hawkins, N. Ru, J. Dong, G. Stoica, C.A. Griffin, T. Ichikawa, J.C. Barrett, J.T. Isaacs. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 54:6249\u20136256 (1994).","journal-title":"Cancer Res."},{"key":"7_CR69","first-page":"1142","volume":"56","author":"KA Cooney","year":"1996","unstructured":"K.A. Cooney, J.C. Wetzel, S.D. Merajver, J.A. Macoska, T.P. Singleton, and K.J. Wojno. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res. 56:1142\u20131145 (1996).","journal-title":"Cancer Res."},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1126\/science.7754374","volume":"268","author":"JT Dong","year":"1995","unstructured":"J.T. Dong, P.W. Lamb, C.W. Rinker-Schaeffer, J. Vukanovic, T Ichikawa, J.T. Isaacs, and J.C. Barrett. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC) 268:884\u20136 (1995).","journal-title":"Science (Washington DC)"},{"key":"7_CR71","first-page":"1002","volume":"55","author":"X Gao","year":"1995","unstructured":"X. Gao, A. Zacharek, A. Salkowski, D. Grignon, W. Sakr, A.T. Porter, and K.V. Honn. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res. 55:1002\u20131005 (1995).","journal-title":"Cancer Res."},{"key":"7_CR72","first-page":"1241","volume":"11","author":"X Gao","year":"1995","unstructured":"X. Gao, A. Zacharek, D. Grignon, W. Sakr, A.T. Porter, and K.V. Honn. Localization of potential tumor suppressor loci to a <2 Mb region on chromosome 17q in human prostate cancer. Oncogene 11:1241\u20131247 (1995).","journal-title":"Oncogene"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/canjclin.46.1.5","volume":"65","author":"SL Parker","year":"1996","unstructured":"S.L. Parker, T. Tong, S. Bolden, and P.A. Wingo. Cancer statistics 1996. Ca Cancer J Clin. 65:5\u201327 (1996).","journal-title":"Ca Cancer J Clin."},{"key":"7_CR74","first-page":"2498","volume":"51","author":"A Chiarodo","year":"1991","unstructured":"A. Chiarodo. National cancer institute roundtable on prostate cancer: Future research directions. Cancer Res. 51:2498\u20132505 (1991).","journal-title":"Cancer Res."},{"key":"7_CR75","doi-asserted-by":"publisher","first-page":"804","DOI":"10.7326\/0003-4819-118-10-199305150-00008","volume":"118","author":"MB Garnick","year":"1993","unstructured":"M.B. Garnick. Prostate Cancer: Screening, diagnosis, and management. Ann Int Med 118:804\u2013818 (1993).","journal-title":"Ann Int Med"},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF00666105","volume":"13","author":"KV Honn","year":"1994","unstructured":"K.V. Honn, D.G. Tang, X. Gao, I.A. Butovich, B. Lui, J. Timar, W. Hagmann. 12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev. 13:365\u2013396 (1994).","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"7_CR77","first-page":"3","volume":"11","author":"X Gao","year":"1995","unstructured":"X. Gao, and K.V. Honn. 12-lipoxygenase and 12(S)-HETE in cancer invasion and metastasis. Adv. Oncol. 11(2):3\u20138 (1995).","journal-title":"Adv. Oncol."},{"issue":"3","key":"7_CR78","first-page":"2","volume":"11","author":"X Gao","year":"1995","unstructured":"X. Gao, and K.V. Honn. 12-lipoxygenase as a prostate cancer marker and therapeutic target. Adv. Oncol. 11(3):2\u20138 (1995).","journal-title":"Adv. Oncol."},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0090-4295(99)80198-8","volume":"46","author":"X Gao","year":"1995","unstructured":"X. Gao, D. Grignon, T. Chbihi, A. Zacharek, Y.Q. Chen, W. Sakr, A.T. Porter, J.D. Crissman, J.E. Pontes, I.J. Powell, and K.V. Honn. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urol. 46:227\u2013237 (1995).","journal-title":"Urol."}],"container-title":["Advances in Experimental Medicine and Biology","Eicosanoids and other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-1813-0_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T16:37:42Z","timestamp":1557938262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-1813-0_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"ISBN":["9781489918154","9781489918130"],"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-1813-0_7","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}